- $263.52m
- $381.88m
- $142.81m
- 66
- 93
- 45
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 97.4 | 105 | 109 | 110 | 112 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 94.8 | 96.3 | 113 | 98.9 | 109 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 47.7 | 46.5 | 57.2 | 44.9 | 46.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 36 | 35.4 | 43 | 33.7 | 34.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 36 | 35.4 | 43 | 33.7 | 34.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 36 | 35.4 | 43 | 33.7 | 34.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.33 | 2.32 | 2.8 | 2.24 | 1.59 |
Dividends per Share |